The 🐍🐍🐍 have been hot in the second half. Check out my thoughts on who to scoop for the fantasy stretch:
📈 Suarez, Bell
↔️ Pederson, McCarthy
🤔 Perdomo, Del Castillo
@RotoBallerMLB@RotoBaller#FantasyBaseball#Fantasy
https://t.co/oz9MEOpNVg
Some thoughts on the MLB hot stove ♨️
Who’s value will benefit from a trade and who could see a drop off?
📈 Crochet, Robert, Pillar
↔️ Miller
📉 Kopech
@RotoBallerMLB@RotoBaller
https://t.co/FWxWz3bG9a
Embiid, Maxey, and PG… Daryl Morey you’ve outdone yourself.
Let’s sign Allen Iverson as our 12th man (a la UD Haslem with The Heat) and the trophy is ours.
@sixers
Took a deep dive 🤿 to find value hiding in plain sight on the waiver wire.
Check out this list to fill specific pitching needs:
🔥Strikeouts: Bradley
↔️Ratio Help: Gray, Taillon
@RotoBallerMLB@RotoBaller
https://t.co/sUnruRRcTw
Fascinating supportive tech. Can’t forget the psychosocial impacts of cancer & treatment!
👉ASC can greatly benefit some breast cancer pts
🔑Imperative to discuss benefits, AEs, costs beforehand
🤔How to improve RN support?
@scalpcooling@DigniCap
https://t.co/PT1e9xgJTK
@marklewismd Definitely need to see a pre-LT response to CTX and no lesion larger than 5.5cm! Basically the Oslo Score 🇳🇴
The CEA reduction by 50% is novel from the Oslo group (Dueland et al.)
Most recur to lung, wonder if lung metastasectomy post-LT can provide even more OS?
Awesome!
Survival numbers are incredible.
Oslo 🇳🇴 group has been working on this for nearly a decade with similar (amazing) results.
Barrier in US is organ availability, but ECD organs and new perfusion techniques should address this.
The time is now!
CTx & liver transplantatison vs CTx in pts with unresectable CRC liver metastases at #ASCO24
🔎prospective trial TRANSMET, 94 pts
👉40% excluded, 9 drop out, 81% underwent LTx
👉mPFS 17.4 vs 6.4, 72% recurrence after LTx
👉5yr OS: 57% vs 13%
🧐potential cure for some pts, selection is key
@myESMO@ILCAnews@EASLnews #livertwitter